Efficacy of Zinc Sulfate With Probiotics for the Treatment of Acute Diarrhea in Children
Zinc
Effectiveness and Efficacy of Zinc With Probiotics for the Treatment of Acute Diarrhea in Young Children
1 other identifier
interventional
256
1 country
2
Brief Summary
Diarrheal disease is one of the major causes of morbidity and mortality in children under five. Disease is treated symptomatically with oral rehydration (ORS) as a basic measure. In children with severe zinc deficiency, diarrhea is common and responds quickly to zinc supplementation. Zinc supplementation may also helpful in diarrheal children without zinc deficiency. Effectiveness of zinc was proven in developing countries but was not in Europe. Objective of our study is to assess whether zinc supplementation given with probiotics and ORS is effective in acute diarrhea in children in Poland.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Jul 2010
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 7, 2010
CompletedFirst Posted
Study publicly available on registry
June 9, 2010
CompletedStudy Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedJune 10, 2010
June 1, 2010
1.9 years
June 7, 2010
June 9, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Period of diarrhea in hours
The primary endpoint of our study is the time of acute diarrhea
15 days
Secondary Outcomes (1)
number of stools in consequent days
15 days
Study Arms (2)
Zinc sulfate
EXPERIMENTALChildren in active treatment group will be given zinc sulfate 10-20 mg per day orally plus probiotics
Placebo
PLACEBO COMPARATORChildren will be given placebo plus probiotics
Interventions
Zinc Sulfate in sugar sirup will be given orally in dosis of 10-20 mg per day for 10 days
Eligibility Criteria
You may qualify if:
- Age 1-36 months
- Acute diarrhea defined as 3 or more watery stools per day
- Informed consent (parents)
You may not qualify if:
- Severe dehydration (\> 10%)
- Coexisting severe infection (e.g. sepsis, pneumonia, meningitis)
- Immune deficiency
- Chronic digestive tract disease (e.g. celiac diseases, food allergy)
- Antibiotic therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Szpital im Sw Jadwigi w Trzebicy
Trzebnica, 55-100, Poland
Klinika Pediatrii i Chorob Infekcyjnych Akademii Medycznej we Wroclawiu
Wroclaw, 50-345, Poland
Related Publications (4)
Larson CP, Nasrin D, Saha A, Chowdhury MI, Qadri F. The added benefit of zinc supplementation after zinc treatment of acute childhood diarrhoea: a randomized, double-blind field trial. Trop Med Int Health. 2010 Jun;15(6):754-61. doi: 10.1111/j.1365-3156.2010.02525.x. Epub 2010 Mar 29.
PMID: 20374562BACKGROUNDFajolu IB, Emokpae A, Oduwole AO, Silva BO, Abidoye RO, Renner JK. Zinc supplementation in children with acute diarrhoea. Nig Q J Hosp Med. 2008 Apr-Jun;18(2):101-3. doi: 10.4314/nqjhm.v18i2.44997.
PMID: 19068562BACKGROUNDBoran P, Tokuc G, Vagas E, Oktem S, Gokduman MK. Impact of zinc supplementation in children with acute diarrhoea in Turkey. Arch Dis Child. 2006 Apr;91(4):296-9. doi: 10.1136/adc.2005.079939. Epub 2005 Dec 14.
PMID: 16354711BACKGROUNDRoy SK, Tomkins AM, Akramuzzaman SM, Behrens RH, Haider R, Mahalanabis D, Fuchs G. Randomised controlled trial of zinc supplementation in malnourished Bangladeshi children with acute diarrhoea. Arch Dis Child. 1997 Sep;77(3):196-200. doi: 10.1136/adc.77.3.196.
PMID: 9370894RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Leszek Szenborn, Prof
Wroclaw Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 7, 2010
First Posted
June 9, 2010
Study Start
July 1, 2010
Primary Completion
June 1, 2012
Study Completion
June 1, 2012
Last Updated
June 10, 2010
Record last verified: 2010-06